Cargando...
Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions
Several recent studies have shown that a single intravenous subanesthetic dose of ketamine, a NMDA receptor antagonist, exerts rapid antidepressant effects in patients with treatment refractory mood disorders and reduces suicidal ideation. Those insights have fueled tremendous excitement in the effo...
Gardado en:
| Publicado en: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2013
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6493512/ https://ncbi.nlm.nih.gov/pubmed/23578128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12103 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|